BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21478551)

  • 1. Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation.
    Kurotani R; Okumura S; Matsubara T; Yokoyama U; Buckley JR; Tomita T; Kezuka K; Nagano T; Esposito D; Taylor TE; Gillette WK; Ishikawa Y; Abe H; Ward JM; Kimura S
    J Biol Chem; 2011 Jun; 286(22):19682-92. PubMed ID: 21478551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
    Cai Y; Kimura S
    PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
    Cai Y; Yoneda M; Tomita T; Kurotani R; Okamoto M; Kido T; Abe H; Mitzner W; Guha A; Kimura S
    BMC Pulm Med; 2015 Jul; 15():72. PubMed ID: 26178733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis.
    Cai Y; Winn ME; Zehmer JK; Gillette WK; Lubkowski JT; Pilon AL; Kimura S
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L10-22. PubMed ID: 24213919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
    Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling.
    Zhao Y; Geverd DA
    Biochem Biophys Res Commun; 2002 Jun; 294(2):319-23. PubMed ID: 12051713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
    Liu L; Lu W; Ma Z; Li Z
    Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipids in pulmonary fibrosis.
    Huang LS; Natarajan V
    Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.
    Chu H; Shi Y; Jiang S; Zhong Q; Zhao Y; Liu Q; Ma Y; Shi X; Ding W; Zhou X; Cui J; Jin L; Guo G; Wang J
    Sci Rep; 2017 May; 7(1):2252. PubMed ID: 28533545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
    Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
    J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
    Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
    J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretoglobin 3A2 protects lung from developing cigarette smoke-induced pulmonary emphysema.
    Kurotani R; Ono S; Miyano Y; Nakayama S; Liu H; Aibara D; Sakahara S; Sato M; Sato K; Inoue S; Shibata Y; Lee MP; Abe H; Kimura S
    Int J Biochem Cell Biol; 2023 Apr; 157():106390. PubMed ID: 36796505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
    Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
    Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
    Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
    Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.